Benzinga | May 6, 2021 08:44AM EDT

Intellia Therapeutics Q1 EPS $(0.69) Misses $(0.67) Estimate, Sales $6.45M Miss $8.57M Estimate

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.67) by 2.99 percent. This is a 9.52 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $6.45 million which missed the analyst consensus estimate of $8.57 million by 24.80 percent. This is a 50.10 percent decrease over sales of $12.92 million the same period last year.